CASC15 gene polymorphisms reduce neuroblastoma risk in Chinese children

18Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

In this case-control study, we analyzed the association between three single nucleotide polymorphisms (SNPs) in the CASC15 gene (rs6939340 A > G, rs4712653 T > C, and rs9295536 C > A) and neuroblastoma susceptibility in the Guangdong and Henan populations of China. We genotyped and analyzed 118 cases and 281 control subjects from Henan province and combined them with previously published data from the Guangdong population. In the Henan population, only the rs6939340 G > A variant homozygote AA was associated with decreased neuroblastoma risk [AA vs. GG: adjusted odds ratio (OR) = 0.47, 95% confidence interval (CI) = 0.23-0.98; P=0.045]. All three polymorphisms, individually and in combination, were associated with decreased neuroblastoma susceptibility in the Guangdong population. Moreover, subjects carrying 1-3 of these protective genotypes had lower neuroblastoma susceptibility than non-carriers (adjusted OR=0.65, 95% CI=0.51-0.84, P=0.0007). These results show that all three genetic variants of CASC15 identified in a genomewide association study (GWAS) decrease neuroblastoma risk in two distinct Chinese populations.

Cite

CITATION STYLE

APA

Zhang, J., Zhuo, Z. J., Wang, J., He, J., Yang, L., Zhang, D., … Yan, L. (2017). CASC15 gene polymorphisms reduce neuroblastoma risk in Chinese children. Oncotarget, 8(53), 91343–91349. https://doi.org/10.18632/oncotarget.20514

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free